Osteoblasts are specialized bone-forming cells crucial for the development, maintenance, and repair of the skeletal system. Derived from mesenchymal stem cells, these cells play a pivotal role in bone metabolism. Osteoblasts synthesize and secrete organic components of the bone matrix, including collagen and other proteins, forming an essential framework for bone mineralization. Through a process called osteogenesis, osteoblasts actively participate in the mineralization of the bone matrix by promoting the deposition of hydroxyapatite crystals, imparting strength and rigidity to bones. Osteoblasts function in coordination with osteoclasts, the cells responsible for bone resorption, maintaining a delicate balance in bone remodeling. This dynamic equilibrium is crucial for skeletal health, ensuring proper bone turnover and repair in response to mechanical stress or injury. Osteoblasts also produce various signaling molecules, such as osteocalcin, involved in the regulation of bone formation and glucose metabolism. The differentiation of osteoblasts is tightly regulated by various signaling pathways, hormones like parathyroid hormone (PTH), and transcription factors, including Runx2 and osterix. Abnormalities in osteoblast function can lead to skeletal disorders like osteoporosis or osteogenesis imperfecta. Additionally, osteoblasts are vital targets in the development of therapeutic strategies for bone-related diseases, as their intricate involvement in bone formation makes them a key focus in bone tissue engineering and regenerative medicine. Understanding the biology of osteoblasts contributes significantly to advancing treatments for bone disorders and promoting overall musculoskeletal health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States